Loading...
Tumour heterogeneity and the evolution of polyclonal drug resistance
Cancer drug resistance is a major problem, with the majority of patients with metastatic disease ultimately developing multidrug resistance and succumbing to their disease. Our understanding of molecular events underpinning treatment failure has been enhanced by new genomic technologies and pre‐clin...
Na minha lista:
| Udgivet i: | Mol Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528620/ https://ncbi.nlm.nih.gov/pubmed/25087573 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2014.06.005 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|